Rachel Eager
Psychiatric/Mental Health · Gilbert, AZNPI 1962093260
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 377 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 25.9% of the total. Reporting peaked in 2022 at $1,818 and has fallen 50.9% since, to $892 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 377 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Supernus Pharmaceuticals, Inc.$548
- Ironshore Pharmaceuticals Inc.$537
- Lundbeck LLC$509
- Sunovion Pharmaceuticals Inc.$441
- Otsuka America Pharmaceutical, Inc.$376
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,58299%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 127 | $1,719 |
| Supernus Pharmaceuticals, Inc. | 13 | $548 |
| Ironshore Pharmaceuticals Inc. | 31 | $537 |
| Lundbeck LLC | 28 | $509 |
| Sunovion Pharmaceuticals Inc. | 24 | $441 |
| Otsuka America Pharmaceutical, Inc. | 21 | $376 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $323 |
| Corium, LLC | 19 | $315 |
| Tris Pharma Inc | 15 | $280 |
| Vanda Pharmaceuticals Inc. | 12 | $221 |
| Alkermes, Inc. | 10 | $209 |
| Axsome Therapeutics, Inc. | 10 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $191 |
| Johnson & Johnson | 7 | $162 |
| Eisai Inc. | 5 | $99 |
| Vertical Pharmaceuticals, LLC | 5 | $99 |
| Bausch Health US, LLC | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Jazz Pharmaceuticals Inc. | 3 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Adlon Therapeutics L.p. | 2 | $39 |
| Noven Therapeutics, LLC | 2 | $38 |
| Neos Therapeutics, LP | 2 | $28 |
| Almatica Pharma LLC | 1 | $26 |
| Alfasigma USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$309
How this compares
$6,629 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 26 | $339 |
| Clonazepam | 11 | $136 |
| Lamotrigine | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Gilbert
- Diane StrickerGilbert$281K
- Roya NayeriGilbert$15K
- Ann CaseyGilbert$7K
- Nicole LyonsGilbert$7K
- Landis StokumGilbert$7K
- Jeffrey ScottGilbert$7K
- Marcus DanielsGilbert$6K
- Sarah ButtlesGilbert$6K
- Melanie LaubGilbert$5K
- Elizabeth ElliottPhoenix$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.